中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/2414
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1999323      Online Users : 443
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > China Medical University Hospital > Jurnal articles >  Item 310903500/2414
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/2414


    Title: A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis
    Authors: 劉耀隆(Yao-Lung Liu);高銘聰(Min-Tsung Kao);黃秋錦(Chiu-Ching Huang)*
    Contributors: 中國附醫內科部腎臟科
    Keywords: Hepatitis B vaccination;End-stage renal disease (ESRD);Hemodialysis (HD);Peritoneal dialysis (PD)
    Date: 2005
    Issue Date: 2009-08-20 17:30:37 (UTC+8)
    Abstract: The doses of hepatitis B vaccine given to peritoneal dialysis (PD) patients are currently based on responsiveness data from hemodialysis (HD) patients. To determine whether the doses are also appropriate from PD patients, we did a head-to-head comparison of short-term and 2-year responses to hepatitis B vaccination of HD patients and PD patients. We evaluated serum titers of the antibody to hepatitis B surface antigen (anti-HBs) after the patients had completed a course of four consecutive intramuscular vaccinations (40 μg of Engerix-B administered into the deltoid muscle at 0, 1, 2, and 6 months) in 69 dialysis patients (47 HD and 22 PD patients) who were both hepatitis B surface antigen (HBsAg) and anti-HBs negative. No patients had received a hepatitis B vaccination prior to the study. There was no significant difference in response to hepatitis B vaccination between the HD and PD groups (78.7% versus 77.3%, p = 0.33). The seroconversion rate defined as anti-HBs ≥ 10 IU/L was influenced only by age (p = 0.011). There was also no significant difference in responsiveness between the HD and PD groups (60% versus 50%, p = 0.41) at a 2-year follow-up. We conclude that doses of HBV vaccine being used for HD patients are also appropriate for PD patients and a booster dose of vaccine is required to maintain seroprotection for those who lost protecting anti-HBs.
    Relation: VACCINE23(00):3957~3960
    Appears in Collections:[China Medical University Hospital] Jurnal articles

    Files in This Item:

    File SizeFormat
    0KbUnknown431View/Open


    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback